| Literature DB >> 35393565 |
Eiji Kobayashi1, Aishun Jin1,2,3, Hiroshi Hamana1, Kiyomi Shitaoka1,4, Kazuto Tajiri1,5, Seisuke Kusano6, Shigeyuki Yokoyama6, Tatsuhiko Ozawa1, Tsutomu Obata7, Atsushi Muraguchi1, Hiroyuki Kishi8.
Abstract
It is commonly understood that T cells are activated via trans interactions between antigen-specific T-cell receptors (TCRs) and antigenic peptides presented on major histocompatibility complex (MHC) molecules on antigen-presenting cells. By analysing a large number of T cells at the single-cell level on a microwell array, we show that T-cell activation can occur via cis interactions (where TCRs on the T cell interact with the antigenic peptides presented on MHC class-I molecules on the same cell), and that such cis activation can be used to detect antigen-specific T cells and clone their TCR within 4 d. We used the detection-and-cloning system to clone a tumour-antigen-specific TCR from peripheral blood mononuclear cells of healthy donors. TCR cloning by leveraging the cis activation of T cells may facilitate the development of TCR-engineered T cells for cancer therapy.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35393565 DOI: 10.1038/s41551-022-00874-6
Source DB: PubMed Journal: Nat Biomed Eng ISSN: 2157-846X Impact factor: 29.234